Sector dividends Celltrion, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 11/12/2025			5-day change	1st Jan Change
186,700.00 ^KRW	+0.54%		+1.85%	+3.56%

03:28pm	Celltrion USA, Inc. announced that it expects to receive $532.1 million in funding from Celltrion, Inc.	CI
12-03	Celltrion Announces U.S. FDA Approval of 300mg strength of OMLYCLO®?	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Dividend Yield (N)	Dividend Yield (N+1)	P/E (N)	Price to Book (N)	EV / Sales (N)	EV / EBITDA (N)	EV / EBIT (N)	Capi.($)
CELLTRION, INC.	0.4%	0.43%	52.16x	2.31x	10.06x	28.46x	37x	27.64B
LONZA GROUP AG	0.92%	1.05%	37.38x	3.85x	5.47x	18.46x	26.93x	47.04B
IQVIA HOLDINGS INC.	-.--%	-.--%	31.38x	5.98x	3.17x	13.68x	21.44x	37.96B
BEONE MEDICINES AG	-.--%	-.--%	103.67x	8.93x	6.31x	63.34x	97.97x	35.71B
MEDPACE HOLDINGS, INC.	-.--%	-.--%	37.88x	37.82x	6.13x	27.85x	29.18x	15.8B
REVOLUTION MEDICINES, INC.	-.--%	-.--%	-13.96x	9.49x	5440.03x	-13.13x	-12.98x	15.06B
ICON PUBLIC LIMITED COMPANY	-.--%	-.--%	28.78x	1.52x	2.13x	10.89x	12.12x	14.19B
TEMPUS AI, INC.	-.--%	-.--%	-50.51x	32.91x	10.9x	28046.62x	-202.34x	13.36B
IONIS PHARMACEUTICALS, INC.	-.--%	-.--%	-34.92x	46.25x	13.19x	-37.66x	-33.01x	12.74B
ASCENDIS PHARMA A/S	-.--%	-.--%	-51.56x	1329.11x	14.56x	-119.34x	-84.57x	12.3B
EUROFINS SCIENTIFIC SE	1.11%	1.21%	22.55x	1.97x	1.89x	8.6x	13.18x	11.85B
QIAGEN N.V.	0.46%	0.41%	23.76x	2.61x	4.92x	13.32x	16.62x	9.9B
BIO-TECHNE CORPORATION	0.53%	0.53%	47.4x	4.36x	7.69x	21.71x	23.67x	9.48B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-.--%	-.--%	46.47x	2.72x	2.88x	11.95x	14.54x	9.59B
PHARMARON BEIJING CO., LTD.	0.7%	0.86%	29.81x	3.45x	3.65x	15.05x	23.66x	6.95B
PRAXIS PRECISION MEDICINES, INC.	-.--%	-.--%	-20.01x	6.92x	22402.32x	-19.28x	-18.65x	6.54B
KYMERA THERAPEUTICS, INC.	-.--%	-.--%	-25.66x	7.78x	104.92x	-17.75x	-16.81x	6.47B
Average	0.24%	0.26%	15.57x	88.70x	1,649.43x	1,651.34x	-3.06x	17.21B
Weighted average by Cap.	0.28%	0.31%	28.86x	65.49x	788.99x	1,291.67x	11.95x